Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
InChi: InChI=1S/C15H20O3/c1-12(2)10-11-18-15(16)9-6-13-4-7-14(17-3)8-5-13/h4-9
2007 Nov 15
It promotes isolated rat liver mitochondrial energy metabolism
It effectively inhibits the proliferation of EZH2 mutant DLBCL cell lines
Formula: C22H24ClN3O4
Retigabine dihydrochloride Catalog No.:M9949-10 InChi: InChI=1S/C15H20O3/c1-12(2)10-11-18-15(16)9-6-13-4-7-14(17-3)8-5-13/h4-9Ezogabine, also known as Retigabine, is an anticonvulsant used as an adjunctive treatment for partial epilepsies in treatment experienced adult patients. The drug was developed by Valeant Pharmaceuticals and GlaxoSmithKline. Ezogabine works primarily as a potassium channel openerthat is, by activating a certain family of voltage gated potassium channels in the brain. This mechanism of action is unique among antiepileptic drugs, and may hold promise
US$ 149.95
US$ 142.00
US$ 49.95
US$ 146.95